ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.210
-0.020 (-1.63%)
Nov 20, 2024, 4:00 PM EST - Market closed
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $63.82 million as of November 21, 2024. Its market cap has decreased by -85.70% in one year.
Market Cap
63.82M
Enterprise Value
-67.40M
1-Year Change
-85.70%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $63.82M, a decrease of -93.96%. That is a compound annual growth rate of -47.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 64.87M | -91.25% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InspireMD | 67.04M |
| HeartBeam | 66.41M |
| Forian | 65.32M |
| electroCore | 65.05M |
| Cue Biopharma | 65.02M |
| Pheton Holdings | 64.84M |
| Cryo-Cell International | 64.82M |
| Monogram Technologies | 64.67M |